Zacks Research Issues Optimistic Estimate for GSK Earnings
GSK plc (NYSE:GSK – Free Report) – Equities researchers at Zacks Research upped their Q2 2025 earnings per share (EPS) estimates for shares of GSK in a report released on Wednesday, May 21st. Zacks Research analyst E. Bagri now expects that the pharmaceutical company will earn $1.08 per share for the quarter, up from their […]
